A novel elastase inhibitor from Aspergillus flavus AFLEI was isolated, and biochemical properties of AFLEI were examined. Column chromatography using diethylaminoethyl DE 52-Cellulose and Sephadex G-75 was used to purify the inhibitor. The final preparation was found to be homogeneous as indicated by a single band after disc polyacrylamide gel PAGE and isoelectric focusing electrophoreses. AFLEI had a molecular weight of 7,525.8 as determined by TOF-MS time of flight mass spectrometry . The elastolytic activity of elastases from A. flavus, A. fumigatus and human leukocytes were inhibited by AFLEI. However, this activity from porcine pancreas elastase, trypsin, chymotrypsin, thrombin, and Ac 1 -Proteinase from snake venom was not affected by AFLEI. The fibrinogenase activity of the elastase from A. flavus was inhibited by AFLEI. AFLEI was inhibited by 2 -macroglobulin. However, ethylenediaminetetraacetic acid EDTA-2Na , benzamidine, chymostatin, tosyl phenylalanine chloromethyl ketone TPCK and dithiothreitol DTT did not show any inhibitory effect on the elastase inhibitory activity of AFLEI.
INTRODUCTION
Aspergillosis is a common mycosis in immunocompromised hosts undergoing chemotherapy. It is caused by inhalation of high spore concentrations of the Aspergillus species. It is reported that various proteases are produced from A. fumigatus 1 5 , A. flavus 6, 7 and A. niger 8, 9 . Since 28% of lung tissue is composed of elastin, a strong relationship is suggested between elastase and the pathogenesis of aspergillosis.
From a practical standpoint, elastase-producing strains promote a higher death rate in immunodeficient mice than non-elastase producing strains. Elastase-producing strains destroy lung tissue 10, 11 and an elastase produced by Aspergillus has been confirmed as a definitive virulence factor of aspergillosis 12 .
Frosco et al. 13 observed that the purified monoclonal antibody to elastase derived from A. fumigatus possesses the ability to inhibit the elastase produced by A. fumigatus. Ulinastatin, which contains an enzyme inhibitor, was administered by way of intravenous drip infusion concomitantly with antifungal agents to patients of pulmonary aspergillosis 14 18 . It is very likely that the elastase inhibitor is an effective therapy of aspergillosis.
It has been shown that A. fumigatus and A. flavus produced elastase inhibitors 19 , although it had not previously been know that Aspergillus spp. produced this elastase inhibitor. A novel elastase inhibitor from Aspergillus flavus AFLEI is the first reported isolation of an elastase
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Production of elastase inhibitor
A sufficient number of microorganic spores were cultured in 100 ml synthetic medium of 0.1% yeast carbon base containing 1% casamino acid as a nitrogen source. The cultures were incubated for 7 days at 37 C without shaking. The culture broth was filtered aseptically through a 0.22 m pore size membrane filter, and the cell-free culture supernatant was used as the source of crude inhibitor.
Assay for elastolytic activity
Elastolytic activity of the elastase was assayed by the method of diazocoupling measuring pnitroanilide p-NA released from 50 mM STANA in DMSO, which was used as the substrate. To determine the extent of STANA digestion, 0.1 ml of the enzyme solution and 0.9 ml of 50 mM Tris-HCl buffer, pH 7.5, and 20 l of 50 mM STANA solution were incubated for 60 min at 37 C. The reaction was stopped by adding 1 ml of 10% trichloroacetic acid TCA . Then 0.2 ml of 0.1% sodium nitrite, 0.5% ammonium sulfamate and 0.1% N-1-naphtyletylenediamine dihydrochloride were added to the reaction solution and the color developed was read at 550 nm. One unit of STANA hydrolase activity was defined as the amount of enzyme which hydrolyzed one micromol of substrate per minute.
Effects of AFLEI on fibrinogenase and collagenase activities of elastase
Elastase from A. flavus in 10 mM Tris-HCl buffer pH 8.5 was incubated with AFLEI for 15 min, and with 1 mg of fibrinogen or collagen Type I, II, III, IV at 37 C for various time intervals. Following incubation, 0.1 ml of the above reaction mixture was withdrawn for an assay of clottable fibrinogen. Simultaneously, 0.1 ml of the reaction mixture was pipetted into a small test tube and 0.1 ml of buffer containing 10 M urea, 4% sodium dodecyl sulfate, 10 mM phosphate buffer pH 7.2 , and 3% -mercaptoethanol were added. This solution was incubated at 37 C for 6 hr. An aliquot of 20 l was then electrophoresed on a 12% SDS-polyacrylamide gel.
RESULTS

Purification of AFLEI
A sufficient number of microorganic spores were cultured in 100 ml of broth. Elastase inhibitory activity 100 95% was found in 5 8 day culture supernatants. The cultures were incubated for 7 days at 37 C without shaking. Elastase inhibitory activity of the culture supernatant was measured Fig. 1A . The culture broth was filtered, and the cell-free culture supernatant was used as the source of crude inhibitor. Solid ammonium sulfate was added 60% saturation to 100 ml of the culture filtrate supernatant from A. flavus at room temperature. The resulting precipitate was collected by centrifugation at 3,000 r.p.m. at 10 min, and dissolved in an equal volume of the original supernatant in 10 mM Tris-HCl buffer pH 7.5 . This solution was applied on a DE52-Cellulose equilibrated with 10 mM Tris-HCl buffer pH 7.5 . The column was eluted with equilibration buffer and 10 mM Tris-HCl buffer pH 7.5 containing a 0.5 M NaCl gradient 
Properties of AFLEI
The molecular weight of the inhibitor isolated from A. flavus was 7,525.8 as determined by TOF-MS Fig. 2 . The pI value was found to be 7.4 by isoelectric focusing/polyacrylamide gel electrophoresis. Carbohydrate content of AFLEI was calculated to be 0% using glucose as a standard by the method of Morris 20 . The heat stability of AFLEI 0.2 g was investigated in 10 mM Tris-HCl buffer pH 7.5 containing 10 mM NaCl. The inhibitor was heated for 10 min at 37 C, 50 C, 60 C, 80 C, and 100 C, then cooled quickly to 4 C, and inhibitory activity was determined. AFLEI was stable to heat treatment it remained 50% active at 80 C . AFLEI 0.2 g was incubated at 4 C for 24 hr in buffers at various pH values 100 mM acetate buffer, pH 6; 100 mM Tris-HCl buffer, pH 7, 8, 9; 100 mM sodium hydrogen carbonate buffer, pH 10 and the inhibitory activity was determined. It was stable over the pH range of 6-10.
The effect of various inhibitors on AFLEI was also determined. AFLEI was mixed with the inhibitors and incubated for 15 min at 37 C prior to the addition of STANA as substrate to determine the inhibitor effect on its inhibitory activity. AFLEI was shown to be inhibited about 60% only by 2 -macroglobulin. EDTA, benzamidine, chymostatin, TPCK and DTT did not show any inhibitory effect on the elastolytic activity of AFLEI Table 1 .
The effect of AFLEI on various elastases was determined and is shown in Table 2 . Fifty microliters of AFLEI was mixed with 50 l of the purified elastase from A. flavus and incubated for 15 min at 37 C. Then, 0.9 ml of 50 mM Tris-HCl buffer, pH 7.5, and 20 l of 50 mM STANA solution were added and incubated for 60 min at 37 C. The reaction was stopped by adding 1 ml of 10% TCA. Two-tenths ml of 0.1% sodium nitrite, 0.5% ammonium sulfamate, and 0.1% N-1-naphtyletylenediamine dihydrochloride were then added to the solution and the color that developed was read at 550 nm. One unit is defined as the minimal inhibitory dose which did not release p-NA from STANA per minute. Elastases from A. fumigatus, A. flavus and human leukocytes were inhibited 100%, 96.1% and 72.8% by AFLEI. However, porcine pancreas elastase was not inhibited.
The effects of AFLEI on fibrinogenase and collagenase activities of elastase were measured by the method of Ouyang and Teng 21 . Both activities were completely inhibited by AFLEI.
DISCUSSION
Aspergillosis is a common mycosis in immunocompromised hosts undergoing chemotherapy. The pathogenesis of aspergillosis is not clearly understood however the literature results of this research strongly indicate that proteases are significant factors in the pathogenic process 24 purified an elastolytic serine protease of 33,000 from A. fumigatus and determined the primary structure by using an elastin medium. They compared the lethal activity of the elastase producing strain and nonelastase producing strain and reported that the former exhibited lethal activity. They did find that the non-elastase producing strain possessed lethal activity but at a significantly minimal level. Kothary et al. 10 compared the lethal activity of six strains of elastase producing and four strains of non-elastase producing A. fumigatus and their results were comparable to Kolattukudy et al. 24 Furthermore, when the dead murine pulmonary tissue was examined, it was found that elastase producing strains had more broadly invaded the tissue than nonelastase producing strains. Monod et al. 5 reported a similar result with an alkaline protease-deficient mutant, and Blanco et al. 12 presented results on the participation of elastase in pathogenicity. From these results, elastase is very important as pathogen factor.
In a previous report, screening of the elastase inhibitor from Aspergillus was examined 19 with the finding that A. fumigatus and A. flavus did indeed produce an elastase inhibitor. In this report and using the AFL-1 strain, both elastase activity and inhibitor activity were stronger than in the previous 13 strains used.
Development of the material which inhibits leucocyte elastase for the purpose of suppressing internal inflammation is the present focus. For example, ONO-5046 25 is used for the treatment of acute lung disturbance with a general inflammatory reaction symptom-complex. This report is the first that reveals an inhibitor capable of inhibiting leucocyte elastase.
Ogawa et al. 17 reported a clinical effect with a protease inhibitor. When Aspergillus invades the body, it must have nutrients to live. Therefore, it is thought that Aspergillus produces a strong elastase which breaks human tissue and supplies nutrients. Development of Aspergillus weakens, however, if this can be controlled and a rise in the therapeutic effect will result. The selectivity is high, molecular weight is 7,525.8, it is stable to heat and pH, and, as stated above, possesses sufficient potency to intervene in the pathogenic process of Aspergillosis.
In the future we plan to examine AFLEI in more detail by studying it in vivo and focusing on the possibility of using this inhibitor as another drug in the arsenal to prevent Aspergillosis.
